Problem statement: Answer the MCQ question.
Query: Which compound exhibits a 27.245% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCC(=O)Nc1cc(=O)[nH]c2nc(-c3ccc(Cl)cc3)nn12
b: Cc1c([N+](=O)[O-])nnn1-c1cc(Cl)cc(Cl)c1
Answer: a. CCC(=O)Nc1cc(=O)[nH]c2nc(-c3ccc(Cl)cc3)nn12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1cc(=O)[nH]c2nc(-c3ccc(Cl)cc3)nn12
CCC(=O)Nc1cc(=O)[nH]c2nc(-c3ccc(Cl)cc3)nn12
N-[2-(4-chlorophenyl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]propanamide